Pharmacological inhibition of USP7 suppresses growth and metastasis of melanoma cells in vitro and in vivo
Open Access
- 1 September 2021
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 25 (19) , 9228-9240
Abstract
Melanoma is a highly aggressive type of skin cancer. The development of diverse resistance mechanisms and severe adverse effects significantly limit the efficiency of current therapeutic approaches. Identification of the new therapeutic targets involved in the pathogenesis will benefit the development of novel therapeutic strategies. The deubiquitinase ubiquitin–specific protease‐7, a potential target for cancer treatment, is deregulated in types of cancer, but its role in melanoma is still unclear. We investigated the role and the inhibitor P22077 of ubiquitin‐specific protease‐7 in melanoma treatment. We found that ubiquitin‐specific protease‐7 was overexpressed and correlated with poor prognosis in melanoma. Further, pharmacological inhibition of ubiquitin‐specific protease‐7 by P22077 can effectively inhibit proliferation, and induce cell cycle arrest and apoptosis via ROS accumulation–induced DNA damage in melanoma cells. Inhibition of ubiquitin‐specific protease‐7 by P22077 also inhibits melanoma tumour growth in vivo. Moreover, inhibition of ubiquitin‐specific protease‐7 prevented migration and invasion of melanoma cells in vitro and in vivo by decreasing the Wnt/β‐catenin signalling pathway. Taken together, our study revealed that ubiquitin‐specific protease‐7 acted as an oncogene involved in melanoma cell proliferation and metastasis. Therefore, ubiquitin‐specific protease‐7 may serve as potential candidates for the treatment of melanoma.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (31800979, 81874242)
This publication has 38 references indexed in Scilit:
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosisCell Death & Disease, 2013
- Melanoma epidemiology, biology and prognosisEuropean Journal of Cancer Supplements, 2013
- Melanoma metastasis: new concepts and evolving paradigmsOncogene, 2013
- Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7Nature Chemical Biology, 2012
- A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib ResistanceCancer Cell, 2012
- Discovery of Specific Inhibitors of Human USP7/HAUSP Deubiquitinating EnzymeChemistry & Biology, 2012
- Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating EnzymesChemistry & Biology, 2011
- The Multifaceted Roles of USP7: New Therapeutic OpportunitiesCell Biochemistry and Biophysics, 2011
- Mechanisms of Disease: epithelial–mesenchymal transition—does cellular plasticity fuel neoplastic progression?Nature Clinical Practice Oncology, 2008